OLBA HEALTHCARE HOLDINGS, Inc. (2689) AI Stock Analysis

• Market Cap: ¥12.47B
• Dividend Yield: 3.89%
• Average Volume (3M): 9.17K
• Price to Earnings (P/E): 9.2
• Beta (1Y): 0.30
• Revenue Growth: 3.95%
• EPS Growth: -11.14%
• Country: JP
• Employees: 1,354
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Distribution
• EPS (TTM): 48.04
• Shares Outstanding: 6,250,000
• 10 Day Avg. Volume: 4,490
• 30 Day Avg. Volume: 9,170
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,321.00
• Price Target Upside: 13.05% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 81 Outperform
• Price Target: ¥2,377.00 ▲(15.78% Upside)

OLBA HEALTHCARE HOLDINGS, Inc. is well-positioned with strong financial performance and attractive valuation metrics. The stock's bullish technical indicators further enhance its appeal. While profitability margins could improve, the company's low debt levels and strong cash flow generation support its growth potential.

OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model

Company Description

OLBA HEALTHCARE HOLDINGS, Inc. (2689) is a healthcare company focused on providing innovative medical solutions and services across various sectors, including pharmaceuticals, medical devices, and healthcare technology. The company aims to enhance patient outcomes through its diverse portfolio of products and services, which include the development and distribution of prescription medications, over-the-counter products, and advanced medical devices that cater to both healthcare providers and patients.

How the Company Makes Money

OLBA HEALTHCARE HOLDINGS generates revenue through multiple streams, primarily from the sale of its pharmaceutical products and medical devices. The company has established partnerships with healthcare providers, hospitals, and pharmacies, allowing it to distribute its offerings widely. Additionally, OLBA may engage in research and development collaborations with other firms to innovate and bring new products to market, which can lead to licensing and royalty agreements that contribute to its revenue. The company's ability to leverage its technological advancements and maintain strong relationships within the healthcare ecosystem is crucial for sustaining its earnings.

OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview

Summary

OLBA HEALTHCARE HOLDINGS demonstrates strong revenue growth and effective operational management, with improving profit margins and a solid balance sheet marked by low leverage and good returns on equity. However, recent cash flow issues need attention, as they could impact long-term growth and financial stability.

Income Statement

The company has shown strong revenue growth, increasing by 10.34% from 2023 to 2024 TTM, and a robust gross profit margin of 11.49% for TTM. Net profit margin improved to 1.37% compared to the previous year, showing enhanced profitability. EBIT and EBITDA margins are solid at 1.88% and 2.28% respectively, indicating efficient operations. However, the net profit margin remains relatively low, suggesting room for further improvement in profitability.

Balance Sheet

OLBA HEALTHCARE HOLDINGS exhibits a healthy balance sheet with a low debt-to-equity ratio of 0.23, signifying conservative leverage. The company's return on equity (ROE) at 14.45% for TTM reflects effective management of shareholder funds. The equity ratio of 24.59% suggests a stable capital structure, though there is potential to increase equity. Overall, the balance sheet indicates sound financial health with controlled risks.

Cash Flow

Despite fluctuations, the company maintained positive free cash flow in recent periods. However, the lack of operating cash flow in the TTM period is a concern. In the previous year, the operating cash flow to net income ratio was strong, indicating efficient cash generation relative to profit. The company must address the recent cash flow challenges to bolster financial flexibility.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	118.56B	110.47B	107.96B	112.98B	107.90B
Gross Profit	13.60B	12.95B	12.50B	11.60B	11.07B
EBITDA	2.83B	2.68B	2.56B	1.94B	1.16B
Net Income	1.50B	1.41B	1.54B	989.37M	326.41M
Balance Sheet
Total Assets	43.24B	40.88B	39.97B	36.56B	33.68B
Cash, Cash Equivalents and Short-Term Investments	2.73B	2.40B	3.19B	2.16B	1.93B
Total Debt	1.63B	1.92B	1.28B	1.96B	3.91B
Total Liabilities	31.86B	30.55B	30.88B	28.43B	26.40B
Stockholders Equity	11.37B	10.33B	9.09B	8.13B	7.28B
Cash Flow
Free Cash Flow	1.61B	-910.52M	1.97B	2.49B	407.07M
Operating Cash Flow	2.08B	-659.52M	2.42B	3.13B	862.56M
Investing Cash Flow	-673.03M	-306.25M	-211.81M	-630.38M	-496.04M
Financing Cash Flow	-1.09B	175.94M	-1.17B	-2.26B	439.89M

OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2053.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Positive. The current price of 2053 is above the 20-day moving average (MA) of 2048.40, above the 50-day MA of 2033.73, and above the 200-day MA of 1982.26, indicating a bullish trend. The MACD of 6.55 indicates Positive momentum. The RSI at 52.72 is Neutral, neither overbought nor oversold. The STOCH value of 61.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2689.

OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2689	81 Outperform	¥12.47B	9.20		3.89%	3.95%	-11.14%
9265	76 Outperform	¥8.28B	13.01		1.98%	3.06%	-6.60%
3417	75 Outperform	¥17.09B	5.97		2.10%	4.42%	20.59%
3151	70 Outperform	¥58.18B	9.00		3.54%	2.19%	30.09%
3183	70 Outperform	¥38.15B	18.07		3.85%	11.04%	20.33%
4350	70 Outperform	¥15.00B	11.51		2.41%	6.09%	-30.07%
Sector *	51 Neutral	$7.39B	0.36	-62.86%	2.36%	15.48%	-2.68%

OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events

OLBA HEALTHCARE Reports Modest Sales Growth Amid Profit Decline

OLBA HEALTHCARE HOLDINGS, Inc. reported a modest increase in net sales for the nine months ending March 31, 2025, despite a decline in operating and ordinary profits compared to the previous year. The company’s financial position shows a slight increase in total assets and net assets, although the equity ratio decreased. The announcement indicates a stable dividend forecast, with no revisions to the financial results forecast, suggesting a cautious but steady approach to growth and shareholder returns.